EXPERTISE THAT FUELS TRANSFORMATIVE CARE
Our team of scientists, endocrinologists, and oncologists are focused on developing much-needed therapies for people with endocrine diseases and related tumors. Our core expertise is in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology. Our exceptional understanding of patient needs and our uncompromising pursuit of science and medicine fuels our mission to change lives for the better.
Our core areas of discovery
Endocrine Disease
Crinetics is focused on developing innovative nonpeptide drug candidates that target specific endocrine receptors to modulate the pathways they control for the benefit of patients.
Metabolic Disease
We’re combining our understanding of metabolic hormonal pathways and the GPCRs that control them to create new molecules to treat diseases like obesity and diabetes.
Targeted Therapies
We’re pioneering new approaches in oncology that use the infrastructure of the endocrine system to selectively target and treat neuroendocrine and other tumors.
Our science is focused on areas of great unmet needs
Acromegaly develops when a benign pituitary tumor develops and secretes increased levels of growth hormone (GH). Acromegaly is characterized by somatic overgrowth (often in the hands, feet, and face), and other physical changes, joint pain, metabolic disorders, cardiovascular disease, and respiratory problems, among others. When left untreated, acromegaly can lead to premature mortality.
Learn More
Carcinoid syndrome is a collection of symptoms that occur when a subset of neuroendocrine tumors (NETs) actively release excessive amounts of hormones (serotonin and others) that cause debilitating flushing, diarrhea, bronchospasms (weakness and shortness of breath), venous telangiectasia (spider veins), and cardiac valvular lesions. NETs are a rare, heterogenous type of cancer that originate from neuroendocrine cells, most often in the gastrointestinal tract, lungs, and pancreas.
Learn More
Classic CAH is a subset of CAH, a genetic disorder caused by deficiency of the enzyme 21-hydroxylase (21-OH), leading to impaired cortisol synthesis in the adrenal gland. The lack of cortisol results in persistently high levels of adrenocorticotropic hormone (ACTH) secreted by the pituitary gland, leading to an excess of androgens. Elevated androgens can cause infertility, ambiguous genitalia, precocious puberty, and excessive facial hair.
Learn More
Cushing’s syndrome is a disease in which the body makes too much cortisol. One cause of this is a condition known as ACTH-dependent Cushing’s syndrome, which most often develops when a benign pituitary tumor grows and secretes increased levels of ACTH. Increased levels of ACTH result in excessive cortisol secretion by the adrenal glands. Symptoms may include a round and red face, a hump on the back of the neck, purple stretch marks on the chest, armpits, and abdomen, skin changes such as acne, excessive facial hair, easy bruising, and rapid weight gain, especially focused in the abdomen.
Learn MoreJoin us on our mission to redefine the future of endocrinology.
View open positions